Laboratório de Imunologia e Biologia Molecular Instituto de Ciências da Saúde - UFBA

Name

Laboratório de Imunologia e Biologia Molecular Instituto de Ciências da Saúde - UFBA

Legal name

Laboratório de Imunologia e Biologia Molecular Instituto de Ciências da Saúde - UFBA

Website

https://labimuno.ufba.br

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Diagnostics Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAFAMAB

Clinical Chemistry & Immunoassay Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAFAMAD

Microbiology & Infectious Disease Testing Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAFAMAL

Clinical Research & Trial Central Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAGADAH

Cell-Based & Potency Assays (Bioassays)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical Services

Keywords

• Clinical diagnostics services
• Immunology research laboratory
• Molecular biology testing
• Public healthcare diagnostics
• Hereditary cancer screening

Headquarters

HQ city

Salvador, Bahia

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Public Healthcare Services (SUS): The laboratory generates revenue through a service agreement with the Brazilian public healthcare system (SUS), performing approximately 250,000 tests per year for patients referred from the public health network. Revenue from these services funds academic activities, research, and operational maintenance.
2. Research Grants: The laboratory receives competitive research funding from government agencies including CNPq, FINEP, FAPEX, CAPES, and the Fundação Maria Emilia Pedreira Freire de Carvalho to support specific research projects.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Laboratory of Immunology and Molecular Biology (Labimuno) is a university clinical laboratory at UFBA that provides specialized diagnostic testing across eight sectors — Clinical Biochemistry, Hematology, Flow Cytometry Immunophenotyping, Immunology, Oncogenetics and Molecular Biology, Molecular Oncohematology, Prenatal Screening, and Urinalysis — to patients of the Brazilian public healthcare system (SUS) in Salvador and across the state of Bahia, performing approximately 250,000 tests per year. It also operates as the primary base for the Immunology Graduate Program (PPGIm), supporting undergraduate and graduate training, and conducts research in immunology, molecular biology, and applied biotechnology.

Product overview

Laboratório de Imunologia e Biologia Molecular is a university clinical laboratory offering a comprehensive range of diagnostic services organized into eight core testing sectors: Bioquímica Clínica (Clinical Biochemistry), Hematologia (Hematology), Imunofenotipagem por Citometria de Fluxo (Flow Cytometry Immunophenotyping), Imunologia (Immunology), Oncogenética e Biologia Molecular (Oncogenetics and Molecular Biology), Oncohematologia Molecular (Molecular Oncohematology), Triagem Pré-Natal (Prenatal Screening), and Urinálise (Urinalysis). The laboratory serves SUS (Unified Health System) patients from Salvador and interior Bahia, performing approximately 250,000 tests per year. It also supports research and graduate education as part of the Immunology Graduate Program (PPGIm) at UFBA.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioquímica Clínica (Clinical Biochemistry) Clinical biochemistry testing service that measures chemical values of metabolic processes for diagnostic purposes, using advanced technology for precision. Targeted at SUS patients requiring metabolic screening.
• Hematologia (Hematology) Hematology service covering coagulation studies and immunohematology, performing analyses related to blood and its fractions. Targeted at SUS patients requiring blood-related diagnostics.
• Imunofenotipagem por Citometria de Fluxo (Flow Cytometry Immunophenotyping) Flow cytometry immunophenotyping service for diagnosis and treatment monitoring of oncohematological diseases and quantification of stem cells for Bone Marrow Transplantation. Targeted at SUS patients with hematological malignancies and transplant candidates.
• Imunologia (Immunology / Immunodiagnostics) Immunology diagnostic service performing tests essential for diagnosing infectious diseases and providing specialized diagnostic support for patient monitoring. Targeted at SUS patients requiring infectious disease and immunological workups.
• Oncogenética e Biologia Molecular (Oncogenetics and Molecular Biology) Molecular diagnosis service for patients with suspected hereditary cancers, using a panel of 18 susceptibility genes for breast, ovarian, and intestinal tumors, plus MLPA analysis. Targeted at SUS patients with suspected hereditary cancer predisposition.
• Oncohematologia Molecular (Molecular Oncohematology) Molecular oncohematology service for diagnosis, prognosis, and therapeutic monitoring of hematopoietic and lymphoid tissue disorders including myelodysplastic syndromes, leukemias, lymphomas, and myeloma. Targeted at SUS patients with hematological neoplasias.
• Triagem Pré-Natal (Prenatal Screening) State Prenatal Screening Program on Filter Paper within the Rede Cegonha (Stork Network) for the southern and southeastern regions of Bahia state. Targeted at pregnant SUS patients in the program catchment area.
• Urinálise (Urinalysis) Urinalysis service investigating markers that may indicate the presence of asymptomatic pathologies. Targeted at SUS patients requiring urine-based screening.

Quantifiable outcome

• 2,345,084 tests performed over the past 10 years
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Hospital Universitário Prof Edgard Santos (HUPES)coreStrategic or Co-development Partner · 1 August 2019HUPES is a key collaborator in the viral hepatitis research network project. The hospital's hepatology department (Dr. Vinicius Nunes and Dra. Simone Cunha) works with the lab on epidemiological studies, phylogenetic analysis, and antiviral resistance profiling in the Bahia-Amazônia region.
• Universidade Federal de Rondônia (UNIR)minorStrategic or Co-development Partner · 1 August 2019Prof. Juan Miguel Salcedo, infectologist at UNIR, is listed as a national partner in the viral hepatitis research network project coordinated by the lab.
• Instituto de Medicina Tropical de ManausminorStrategic or Co-development Partner · 1 August 2019Prof. Wornei Braga, infectologist, collaborates on viral hepatitis studies as part of the molecular epidemiology network led by the lab.
• Universidade de São Paulo (USP)minorStrategic or Co-development Partner · 1 August 2019Prof. João Renato Ribelo from USP is an international collaborator on the viral hepatitis research network project.
• Hospital Austral de Buenos Aires, ArgentinaminorStrategic or Co-development Partner · 1 August 2019Prof. Marcelo Silva from Hospital Austral in Buenos Aires is an international collaborator on the viral hepatitis project.
• Universidad Nacional de Rosario, ArgentinaminorStrategic or Co-development Partner · 1 August 2019Prof. Fernando Bessone collaborates as an international partner on the viral hepatitis research network.
• Universidade Nacional de Córdoba, ArgentinaminorStrategic or Co-development Partner · 1 August 2019Prof. Maria Belen Pisano, virologist, is an international collaborator on the viral hepatitis molecular epidemiology network.
• Universidade de Málaga, SpainminorStrategic or Co-development Partner · 1 August 2019Prof. Maria Isabel Lucena from the University of Málaga is an international collaborator on the viral hepatitis project.
• Rede Nordeste de Biotecnologia (RENORBIO)coreStrategic or Co-development PartnerThe lab's professors participate in RENORBIO's Graduate Program in Biotechnology, expanding the reach of its graduate training beyond UFBA's own programs.
• UFMG (Universidade Federal de Minas Gerais)coreStrategic or Co-development PartnerSignificant collaboration with UFMG's Molecular Genetics Laboratory (particularly Prof. Vasco Azevedo and Prof. Sérgio Costa), which has been a key partner for Corynebacterium pseudotuberculosis research and genome sequencing projects.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Genomic Engenharia Molecular: Brazilian molecular diagnostics company focused on oncogenetics, hereditary cancer panels, and molecular testing. Direct competitive overlap with Labimuno's oncogenetics and molecular oncohematology service lines, though operating commercially rather than as a university lab.
• Fundação Oswaldo Cruz (Fiocruz) - Instituto de Biologia Molecular do Paraná (IBMP): Brazilian public research institute focused on molecular biology, immunology, and infectious disease diagnostics with public health mission. Strong comparable as a Brazilian public-sector molecular/immunology research lab with both research and public-health service delivery.
• Laboratório Central de Saúde Pública da Bahia (LACEN-BA): Bahia state's public health reference laboratory providing centralized diagnostic and confirmatory testing for the SUS network. Direct comparable in serving Bahia's public health system with complementary diagnostic capabilities including infectious disease and immunology testing.

Broad incumbents

• DASA: Brazil's largest medical diagnostics company operating a nationwide network of clinical laboratories offering clinical biochemistry, hematology, immunology, molecular diagnostics, and genetic testing. Directly comparable in service portfolio but vastly larger scale and private commercial structure.
• Grupo Fleury: One of Brazil's leading diagnostic medicine companies with a broad portfolio across clinical analysis, imaging, and specialized diagnostics including molecular and oncogenetics testing. Comparable service offerings with national reach versus Labimuno's regional SUS-focused model.
• Hospital Israelita Albert Einstein Diagnósticos: Premium Brazilian hospital and reference diagnostics provider operating one of the country's highest-quality clinical laboratories, including advanced molecular and immunology testing. Comparable reference lab capabilities and academic affiliations.
• Quest Diagnostics: U.S.-based global reference laboratory providing clinical chemistry, immunology, molecular diagnostics, and genetic testing at massive scale. Comparable as a reference lab model with similar service breadth, though operates in a private commercial context.
• Hermes Pardini: Brazilian diagnostic laboratory group with strong specialty testing capabilities including molecular diagnostics, immunology, and reference lab services for hospital networks. Comparable specialty portfolio with nationwide commercial footprint.
• LabCorp (Laboratory Corporation of America): Global clinical laboratory network providing routine and esoteric diagnostic testing including immunology, molecular diagnostics, and oncology genetics at massive scale. Comparable as a reference laboratory operator with similar service mix though vastly larger and commercial.
• Sabin Medicina Diagnóstica: Large Brazilian diagnostic chain with extensive coverage across multiple states including Bahia, offering clinical analysis, immunology, molecular diagnostics, and specialty testing. Competes in the same regional geography with private-sector agility.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/laborat%C3%B3rio-de-imunologia-e-biologia-molecular-instituto-de-ci%C3%AAncias-da-sa%C3%BAde-ufba

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratório de Imunologia e Biologia Molecular Instituto de Ciências da Saúde - UFBA